Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Florida Medicaid Program Yields Savings Of $42 Mil. After Two Years

This article was originally published in The Pink Sheet Daily

Executive Summary

The company expects that the savings data exceeding the program's original goal will support a legislative change allowing Medicaid disease management programs in lieu of supplemental rebates to continue. The "Healthy State" initiative is slated to expire in September 2005.

You may also be interested in...



Employer Enthusiasm For Disease Management Is Waning, Insurers Say

PBMI Prescription Drug Utilization Conference attendees express caution about the motives of pharmaceutical manufacturer-sponsored disease management programs. Preliminary results from PBMI’s 2005 benefit design report found that a lower percentage of employers are using disease management programs.

Employer Enthusiasm For Disease Management Is Waning, Insurers Say

PBMI Prescription Drug Utilization Conference attendees express caution about the motives of pharmaceutical manufacturer-sponsored disease management programs. Preliminary results from PBMI’s 2005 benefit design report found that a lower percentage of employers are using disease management programs.

Pfizer Optimistic On Florida Medicaid Program As State Moves To Let Contract Expire

Legislation signed by Gov. Jeb Bush would end the Pfizer "Healthy State" program when the contract expires in September 2005. A state report suggests savings from the program have barely exceeded costs. Pfizer expects a report due in August to prove the value of its disease management initiative.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel